AbCellera Biologics Inc. ABCL Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s cash provided by (used in) operating activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s cash provided by (used in) operating activity, including discontinued operation?
- AbCellera Biologics Inc. (ABCL) reported cash provided by (used in) operating activity, including discontinued operation of -$33.52M in Q1 2026.
- How has AbCellera Biologics Inc.'s cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
- AbCellera Biologics Inc.'s cash provided by (used in) operating activity, including discontinued operation decreased by 190.1% year-over-year, from -$11.55M to -$33.52M.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.